The slip
PARKINSON RECEIPTno. 1104
17 Oct 2026, 14:32 UTCdopamine neurons, braak
predictionST3GAL4 in dopamine neurons tracks Braak Lewy-body stage
registered5d1bc58d63f06a80
discovery-0.46 p=0.214 n=9
replication-0.48 p=0.190 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.46, p 0.214)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT2f17286072b6d327fd026b9c…
follows 465ab4a194f8…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 1104: ST3GAL4 in dopamine neurons, braak
- power
- full sample -0.39 (p 0.107, n 18), 95% CI -0.73 to +0.09. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.43 (p 0.072, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.44 (p 0.070, n 18). could be the mix.
- skeptic
- leave-one-out range -0.49 to -0.32, sign flips 0; without severely affected donors -0.39 (p 0.107, n 18). fragile.
- cell type
- strongest in oligodendrocytes: -0.71 (p 0.0010, n 18) vs -0.39 in dopamine neurons. proposing oligodendrocytes.
- axis
- no measure beats "tracks Braak Lewy-body stage" for ST3GAL4 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up ST3GAL4 · oligodendrocytes · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) -0.57 p 0.041 (needs p < 0.0012)